Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pharmaceutical Poisoning: Treatment Strategies

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Acute Pyelonephritis II: Diagnostic Studies and Management

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ebola Virus in Pregnancy.

Obstetrics and gynecology·2026

Same author

Derivation and validation of clinical prediction models for viral etiologies of acute diarrhea in North American children presenting for emergency care.

medRxiv : the preprint server for health sciences·2026

Same author

Measles Outbreak in a Child Care Facility - Lubbock, Texas, March-April 2025.

MMWR. Morbidity and mortality weekly report·2026

Same author

Health, economic, and equity impact of a COVID-19 mobile vaccine clinic program in US: a cost-effectiveness analysis.

Lancet regional health. Americas·2026

Same author

Intramuscular Immunoglobulin for Measles Postexposure Prophylaxis.

NEJM evidence·2026

Same author

Association between Weather Variables and Viral Gastroenteritis in the United States.

medRxiv : the preprint server for health sciences·2026

Search research articles

Related Experiment Video

Updated: Apr 30, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Pediatric anthrax clinical management.

John S Bradley, Georgina Peacock, Steven E Krug

|April 30, 2014

Summary

This summary is machine-generated.

This guidance provides clinical recommendations for treating Bacillus anthracis infections in children following a potential bioterrorism event. It addresses prophylaxis and treatment tailored to pediatric patients up to age 21.

Keywords:

anthrax anthrax vaccine biological weapon bioterrorism children pediatrics prophylaxis

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

Related Experiment Videos

Last Updated: Apr 30, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

Area of Science:

Infectious Diseases
Public Health
Pediatrics

Background:

Anthrax is a zoonotic disease caused by Bacillus anthracis.
Bacillus anthracis can be a biological weapon, leading to rapid, fatal systemic disease if untreated.
Children have unique physiological characteristics that require specific clinical guidance.

Purpose of the Study:

To provide clinical guidance for the prophylaxis and treatment of anthrax in children.
To address the unique needs of pediatric patients (up to age 21) in the event of a deliberate Bacillus anthracis release.
To offer recommendations that differ from adult guidelines when necessary.

Main Methods:

Review of existing clinical data and expert consensus on anthrax treatment.
Adaptation of adult treatment protocols for pediatric populations.
Consideration of age-specific dosing and administration routes.

Main Results:

Specific recommendations for antibiotic prophylaxis and treatment regimens for pediatric anthrax.
Guidance on managing different routes of infection in children.
Considerations for monitoring and supportive care in pediatric patients.

Conclusions:

Standardized clinical guidance is crucial for managing pediatric anthrax post-release.
Tailored pediatric protocols are essential for effective prophylaxis and treatment.
Preparedness for bioterrorism events involving Bacillus anthracis must include specific pediatric considerations.